Codexis Inc
General ticker "CDXS" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $365.7M
Codexis Inc follows the US Stock Market performance with the rate: 42.3%.
Estimated limits based on current volatility of 4.5%: low 4.96$, high 5.43$
Factors to consider:
- China accounted for 28.9% of revenue in the fiscal year ended 2023-12-31
- US accounted for 19.5% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.93$, 4.65$]
- 2024-12-30 to 2025-12-30 estimated range: [2.72$, 5.88$]
Financial Metrics affecting the CDXS estimates:
- Negative: Non-GAAP EPS, $ of -0.75 <= 0.10
- Negative: Operating profit margin, % of -49.25 <= 1.03
- Negative: Operating cash flow per share per price, % of -23.26 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
Short-term CDXS quotes
Long-term CDXS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $104.75MM | $138.59MM | $70.14MM |
| Operating Expenses | $127.45MM | $173.47MM | $138.21MM |
| Operating Income | $-22.70MM | $-34.88MM | $-68.07MM |
| Non-Operating Income | $1.61MM | $1.56MM | $-8.10MM |
| Interest Expense | $0.00MM | $1.44MM | $0.00MM |
| R&D Expense | $55.92MM | $80.10MM | $58.88MM |
| Income(Loss) | $-21.09MM | $-33.32MM | $-76.17MM |
| Taxes | $0.19MM | $0.28MM | $0.07MM |
| Profit(Loss) | $-21.28MM | $-33.59MM | $-76.24MM |
| Stockholders Equity | $164.39MM | $144.80MM | $86.61MM |
| Inventory | $1.16MM | $2.03MM | $2.69MM |
| Assets | $246.38MM | $250.39MM | $136.56MM |
| Operating Cash Flow | $-14.27MM | $11.28MM | $-52.64MM |
| Capital expenditure | $13.83MM | $8.31MM | $4.42MM |
| Investing Cash Flow | $-21.42MM | $-13.58MM | $-4.86MM |
| Financing Cash Flow | $3.77MM | $-0.57MM | $8.17MM |
| Earnings Per Share* | $-0.33 | $-0.51 | $-1.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.